MedTrace Logo

PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"

NCT07491601 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 336

Last updated 2026-03-24

No results posted yet for this study

Summary

This study aims to investigate whether an earlier measurement of parathyroid hormone can reduce the number of patients who develop symptomatic hypoparathyroidism. This will provide evidence for a clear algorithm to address this issue after thyroid surgery. It will lead to an improvement in quality of life and a reduction in the distress experienced by affected patients. In addition, it is conceivable that patients' hospital stay could be shortened.

Conditions

  • Postoperative Hypoparathyroidism
  • Postsurgical Hypoparathyroidism
  • Hypoparathyroidism Post-surgical

Interventions

DRUG

Active vitamin D

Application if parathyroid hormone level falls below normal

DRUG

Calcium

Administered if parathyroid hormone level falls below normal

Sponsors & Collaborators

  • University of Wuerzburg

    collaborator OTHER

  • Nicolas Schlegel

    lead OTHER

Principal Investigators

  • Nicolas Schlegel, Prof. Dr. (MD) · University Hospital Wuerzburg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-08
Primary Completion
2028-12-31
Completion
2029-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07491601 on ClinicalTrials.gov